Clinical Trial Update: F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence [Phase 3]

View source ↗

Summary

Phase 3 trial comparing F-18-PSMA-1007 with F-18-Fluorocholine PET in patients with biochemical recurrence of prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer
• Prostate Cancer Recurrent

Drugs mentioned

• F-18-Fluorocholine
• F-18-PSMA-1007

Snippet

Sponsor: ABX advanced biochemical compounds GmbH | Conditions: Prostate Cancer, Prostate Cancer Recurrent | Phase 3 | Status: COMPLETED